Although originally developed for the treatment of metabolic diseases, GLP-1-based therapies are now recognized for their influence on the same brain systems mediating drug-seeking and reward, suggesting therapeutic potential beyond glycemic control
IGF-1 LR3 in Anabolic and Dexamethasone-Treated Models Tomas FM et al
At the end of the day we all have individual needs, so if you feel most comfortable trying that go for it
Some patients may notice results within a few weeks, while it may take longer for others
Together, these peptides are researched for their complementary effects on GH-related signaling
Monitor for signs of inadequate disease control, such as elevated blood glucose readings, increased thirst, frequent urination, or unexplained weight changes